
    
      The events of recurrence of gastric and/or duodenal ulcers will be evaluated due to a blinded
      manner by specialized endoscopists at pre- and post administration during 12 weeks
      administration of PPI (Rabeprazole sodium 10 mg or 20 mg tablet once a day) or the mucosal
      defensive drug (Gefarnate 50mg Capsule twice a day).
    
  